TY - JOUR
T1 - Acute hemorrhagic necrosis of tumors induced by interleukin-1α effects independent of tumor necrosis factor
AU - Johnson, Candance S.
AU - Chang, Ming Jei
AU - Braunschweiger, Paul G.
AU - Furmanski, Philip
N1 - Funding Information:
Received December 21, 1990; revised March 14, 1991; accepted March 20, 1991. Supported in part by Public Health Service grants CA-48077, CA-45674, CA-33188, and CA-49143 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. C. S. Johnson, M.-J. Chang, Departments of Otolaryngology and Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, Pa. P. G. Braunschweiger, Department of Radiation Oncology, University of Miami, Miami, Fla. P. Furmanski, Department of Biology, New York University, New York, NY. We thank Maureen Topper, Dr Wei-Dong Yu, Dr Camilla Pourbohloul, and Gabrielle Boyle for their assistance in carrying out the experiments and Linda Koch for preparing the manuscript. Correspondence to: Candace S. Johnson, PhD, Department of Otolaryngology, Division of Oncology and Immunology, University of Pittsburgh, School of Medicine, 203 Lothrop St., Rm. 110, Pittsburgh, PA 15213.
PY - 1991/6/19
Y1 - 1991/6/19
N2 - Tumor necrosis factor (TNF), a protein synthesized in response to the endotoxin bacterial lipopolysaccharide (LPS), is the classical mediator of acute hemorrhagic necrosis of tumors. We have demonstrated that interleukin-la (IL-lα), with a spectrum of activities very similar to those of TNF, also causes acute hemorrhagic necrosis of tumors. Both TNF and IL-1 induce a cascade of events including the synthesis or release of each other. The present studies were thus undertaken to determine whether the hemorrhagic necrosis induced in tumors by IL-lα is due to TNF. Kinetic parameters of IL-lα-induced hemorrhage were similar to those observed with recombinant murine TNF-α (TNF-α) or LPS in RIF-1 fibrosarcomas in C3H/HeN (endotoxin-sensitive) mice. However, the amount of TNF found in the sera or tumors of animals treated with LPS was more than 20-fold higher than in mice treated with IL-lα, and LPS induced similar degrees of hemorrhagic necrosis, which was measured by determining the packed volume of red blood cells by 59Fe labeling. A low but significantly hemorrhagic dose of IL-lα induced no detectable TNF in tumors. Pretreatment with 250 μg of neutralizing antibody to TNF had no effect on IL-lα-induced hemorrhage, whereas TNF-α- and LPS-induced hemorrhagic effects were significantly reduced. These results demonstrate an important antitumor activity of IL-αa that appears to be independent of TNF. [J Natl Cancer Inst 83:842-848,1991]
AB - Tumor necrosis factor (TNF), a protein synthesized in response to the endotoxin bacterial lipopolysaccharide (LPS), is the classical mediator of acute hemorrhagic necrosis of tumors. We have demonstrated that interleukin-la (IL-lα), with a spectrum of activities very similar to those of TNF, also causes acute hemorrhagic necrosis of tumors. Both TNF and IL-1 induce a cascade of events including the synthesis or release of each other. The present studies were thus undertaken to determine whether the hemorrhagic necrosis induced in tumors by IL-lα is due to TNF. Kinetic parameters of IL-lα-induced hemorrhage were similar to those observed with recombinant murine TNF-α (TNF-α) or LPS in RIF-1 fibrosarcomas in C3H/HeN (endotoxin-sensitive) mice. However, the amount of TNF found in the sera or tumors of animals treated with LPS was more than 20-fold higher than in mice treated with IL-lα, and LPS induced similar degrees of hemorrhagic necrosis, which was measured by determining the packed volume of red blood cells by 59Fe labeling. A low but significantly hemorrhagic dose of IL-lα induced no detectable TNF in tumors. Pretreatment with 250 μg of neutralizing antibody to TNF had no effect on IL-lα-induced hemorrhage, whereas TNF-α- and LPS-induced hemorrhagic effects were significantly reduced. These results demonstrate an important antitumor activity of IL-αa that appears to be independent of TNF. [J Natl Cancer Inst 83:842-848,1991]
UR - http://www.scopus.com/inward/record.url?scp=0025772156&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025772156&partnerID=8YFLogxK
U2 - 10.1093/jnci/83.12.842
DO - 10.1093/jnci/83.12.842
M3 - Article
C2 - 2061944
AN - SCOPUS:0025772156
SN - 0027-8874
VL - 83
SP - 842
EP - 848
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 12
ER -